articleCell MetabolismAug 18, 2022BRONZE OA

LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept

TCTamer CoşkunSUShweta UrvaWCWilliam C. RoellHQHongchang QuCLCorina Loghin

Eli Lilly (United States)

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

266
total citations
FWCI
31.71
Percentile
100%
References
60
Citations per year

Authors

20

Topics & keywords

Topics
Keywords
  • Glucagon receptor
  • Weight loss
  • Glycemic
  • Agonist
  • Endocrinology
  • Internal medicine
  • Glucagon-like peptide-1
  • Medicine
No related works found for this paper.

Funding